29.8.2007   

EN

Official Journal of the European Union

C 201/22


Prior notification of a concentration

(Case COMP/M.4691 — Schering-Plough/Organon BioSciences)

(Text with EEA relevance)

(2007/C 201/08)

1.

On 23 August 2007, the Commission received a notification of a proposed concentration pursuant to Article 4 of Council Regulation (EC) No 139/2004 (1) by which the undertaking Schering-Plough Corporation (‘Schering-Plough’, United States) acquires within the meaning of Article 3(1)(b) of the Council Regulation control of the whole of the undertaking Organon BioSciences N.V. (‘Organon BS’, the Netherlands) controlled by Akzo Nobel N.V. (‘Akzo’, the Netherlands) by way of purchase of shares.

2.

The business activities of the undertakings concerned are:

for Schering-Plough: human and animal healthcare products,

for Organon BS: human and animal healthcare products.

3.

On preliminary examination, the Commission finds that the notified transaction could fall within the scope of Regulation (EC) No 139/2004. However, the final decision on this point is reserved.

4.

The Commission invites interested third parties to submit their possible observations on the proposed operation to the Commission.

Observations must reach the Commission not later than 10 days following the date of this publication. Observations can be sent to the Commission by fax ((32-2) 296 43 01 or 296 72 44) or by post, under reference number COMP/M.4691 — Schering-Plough/Organon BioSciences, to the following address:

European Commission

Directorate-General for Competition

Merger Registry

J-70

B-1049 Bruxelles/Brussel


(1)  OJ L 24, 29.1.2004, p. 1.